Mariane B. Melo

5.9k total citations · 2 hit papers
49 papers, 3.5k citations indexed

About

Mariane B. Melo is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Mariane B. Melo has authored 49 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 16 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Mariane B. Melo's work include Immunotherapy and Immune Responses (18 papers), Toxoplasma gondii Research Studies (10 papers) and Immune Cell Function and Interaction (7 papers). Mariane B. Melo is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Toxoplasma gondii Research Studies (10 papers) and Immune Cell Function and Interaction (7 papers). Mariane B. Melo collaborates with scholars based in United States, Brazil and United Kingdom. Mariane B. Melo's co-authors include Darrell J. Irvine, Jeroen P. J. Saeij, Kirk D.C. Jensen, Ricardo T. Gazzinelli, Wuhbet Abraham, Daniella Castanheira Bartholomeu, Kelly D. Moynihan, Marcela V. Maus, Ana P. Castaño and Llian Mabardi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Materials.

In The Last Decade

Mariane B. Melo

46 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

2018 542 citations Li Tang, Yiran Zheng et al. Nature Biotechnology profile →
STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity

2022 242 citations Eric L. Dane, Alexis Belessiotis‐Richards et al. Nature Materials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mariane B. Melo United States	27	1.6k	1.2k	838	815	657	49	3.5k
David E. Arnot United Kingdom	32	1.7k 1.0×	1.1k 0.9×	571 0.7×	647 0.8×	209 0.3×	70	5.3k
Gustavo del Real Spain	23	875 0.5×	980 0.8×	687 0.8×	213 0.3×	155 0.2×	47	3.0k
Maria Cristina Roque‐Barreira Brazil	35	1.6k 1.0×	1.5k 1.3×	1.1k 1.3×	608 0.7×	111 0.2×	162	3.9k
Mojgan Bandehpour Iran	26	373 0.2×	989 0.8×	371 0.4×	552 0.7×	195 0.3×	212	2.6k
Stefan Lienenklaus Germany	41	3.5k 2.2×	2.0k 1.7×	761 0.9×	93 0.1×	510 0.8×	108	5.8k
Sagar B. Kudchodkar United States	27	914 0.6×	773 0.6×	640 0.8×	73 0.1×	480 0.7×	45	2.8k
Mats Ohlin Sweden	33	894 0.6×	1.7k 1.4×	567 0.7×	142 0.2×	394 0.6×	166	3.7k
Yasuko Orba Japan	32	863 0.5×	1.2k 1.0×	543 0.6×	95 0.1×	222 0.3×	138	3.9k
Nilabh Shastri United States	54	7.4k 4.5×	4.0k 3.4×	1.4k 1.7×	482 0.6×	234 0.4×	125	10.9k
Norbert Pardi United States	40	2.5k 1.5×	5.1k 4.2×	1.0k 1.2×	179 0.2×	391 0.6×	82	8.5k

Countries citing papers authored by Mariane B. Melo

Since Specialization

Citations

This map shows the geographic impact of Mariane B. Melo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariane B. Melo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariane B. Melo more than expected).

Fields of papers citing papers by Mariane B. Melo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariane B. Melo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariane B. Melo. The network helps show where Mariane B. Melo may publish in the future.

Co-authorship network of co-authors of Mariane B. Melo

This figure shows the co-authorship network connecting the top 25 collaborators of Mariane B. Melo. A scholar is included among the top collaborators of Mariane B. Melo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariane B. Melo. Mariane B. Melo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pires, Ivan S., Gil Covarrubias, Coralie M. Backlund, et al.. (2025). IL-12-releasing nanoparticles for effective immunotherapy of metastatic ovarian cancer. Nature Materials. 25(2). 322–334.

Mohapatra, Somesh, Mariane B. Melo, Jacob Rodriguez, et al.. (2024). Design of Cytotoxic T Cell Epitopes by Machine Learning of Human Degrons. ACS Central Science. 10(4). 793–802. 2 indexed citations

Rodrigues, Kristen A., Christopher A. Cottrell, Jon M. Steichen, et al.. (2023). Optimization of an alum-anchored clinical HIV vaccine candidate. npj Vaccines. 8(1). 117–117. 4 indexed citations

Zhang, Angela Q., Wuhbet Abraham, A Wolff, et al.. (2023). Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR. Nature Biomedical Engineering. 7(9). 1113–1128. 47 indexed citations

Lelis, Felipe, Laura A. Byk, Sergei Pustylnikov, et al.. (2023). Safety, immunogenicity and efficacy of an mRNA-based COVID-19 vaccine, GLB-COV2-043, in preclinical animal models. Scientific Reports. 13(1). 21172–21172. 6 indexed citations

Dane, Eric L., Alexis Belessiotis‐Richards, Coralie M. Backlund, et al.. (2022). STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity. Nature Materials. 21(6). 710–720. 242 indexed citations breakdown →

Smith, Sean G., Ivan S. Pires, Sonia Iyer, et al.. (2022). Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors. Bioengineering & Translational Medicine. 8(2). e10453–e10453. 25 indexed citations

Lu, Zeyu, et al.. (2021). IgG-Engineered Protective Antigen for Cytosolic Delivery of Proteins into Cancer Cells. ACS Central Science. 7(2). 365–378. 10 indexed citations

Steinbach, Sabine, Sasan Jalili‐Firoozinezhad, Sreenidhi Srinivasan, et al.. (2021). Temporal dynamics of intradermal cytokine response to tuberculin in Mycobacterium bovis BCG-vaccinated cattle using sampling microneedles. Scientific Reports. 11(1). 7074–7074. 9 indexed citations

10.

Turner, Hannah L., Raiees Andrabi, Christopher A. Cottrell, et al.. (2021). Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization. Science Advances. 7(31). 24 indexed citations

11.

Smith, Sean G., Santiago Correa, Cathy Nguyen, et al.. (2020). Cancer Cell Coating Nanoparticles for Optimal Tumor-Specific Cytokine Delivery. ACS Nano. 14(9). 11238–11253. 70 indexed citations

12.

Moynihan, Kelly D., Rebecca L. Holden, Naveen K. Mehta, et al.. (2018). Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability. Cancer Immunology Research. 6(9). 1025–1038. 64 indexed citations

13.

Tang, Li, Yiran Zheng, Mariane B. Melo, et al.. (2018). Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery. Nature Biotechnology. 36(8). 707–716. 542 indexed citations breakdown →

14.

Yang, Yu-Sang Sabrina, Kelly D. Moynihan, Ahmet Bekdemir, et al.. (2018). Targeting small molecule drugs to T cells with antibody-directed cell-penetrating gold nanoparticles. Biomaterials Science. 7(1). 113–124. 72 indexed citations

15.

Hassan, Musa A., Mariane B. Melo, Brian J. Haas, Kirk D.C. Jensen, & Jeroen P. J. Saeij. (2012). De novo reconstruction of the Toxoplasma gondii transcriptome improves on the current genome annotation and reveals alternatively spliced transcripts and putative long non-coding RNAs. SHILAP Revista de lepidopterología. 32 indexed citations

16.

Junqueira, Caroline, Bráulia Costa Caetano, Daniella Castanheira Bartholomeu, et al.. (2010). The endless race betweenTrypanosoma cruziand host immunity: lessons for and beyond Chagas disease. Expert Reviews in Molecular Medicine. 12. e29–e29. 131 indexed citations

17.

Bartholomeu, Daniella Castanheira, Catherine Ropert, Mariane B. Melo, et al.. (2008). Recruitment and Endo-Lysosomal Activation of TLR9 in Dendritic Cells Infected with Trypanosoma cruzi. The Journal of Immunology. 181(2). 1333–1344. 54 indexed citations

18.

Rocha-Azevedo, Bruno da, Mariane B. Melo, & Fernando Costa e Silva‐Filho. (2004). Intra-strain clonal phenotypic variation of Tritrichomonas foetus is related to the cytotoxicity exerted by the parasite to cultured cells. Parasitology Research. 95(2). 106–112. 7 indexed citations

19.

Melo, Mariane B., et al.. (2002). Gene transfer of immunoglobulin-fusion proteins into B cells prevents and treats autoimmune diseases. The Journal of Immunology. 168. 4 indexed citations

20.

Melo, Mariane B., et al.. (1996). Glycoinositolphospholipids purified from Trypanosoma cruzi stimulate Ig production in vitro. The Journal of Immunology. 157(11). 4996–5001. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact